Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Muñoz

Showing results (1-10 of 320) with videos related to

Pageof 32
Sort By:
World Journal of Gastroenterology|April 3, 2009
Capsule endoscopyMiguel Muñoz-Navas
Archives of Sexual Behavior|November 7, 2018
Ethnic and Racial Specificity, or Not, in Bisexuality Research: A Practical CommentaryMiguel Muñoz-Laboy
Histology and Histopathology|February 19, 2014
Cancer progression and substance PRafael Coveñas, Miguel Muñoz
Expert Opinion on Therapeutic Patents|May 14, 2020
Neurokinin receptor antagonism: a patent review (2014-present)Miguel Muñoz, Rafael Coveñas
Journal of Clinical Medicine|June 5, 2020
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid LeukemiaMiguel Muñoz, Rafael Coveñas
Cancers|February 13, 2025
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine GliomaMiguel Muñoz, Marisa Rosso
Expert Opinion on Drug Safety|May 28, 2013
Safety of neurokinin-1 receptor antagonistsMiguel Muñoz, Rafael Coveñas
Archivos De Bronconeumologia|October 21, 2023
Long-term Use of Angiotensin-converting Enzyme Inhibitors Increases Substance P Levels, Which is Involved in the Risk of Lung CancerMiguel Muñoz, Antonio Pavon
Anti-Cancer Agents in Medicinal Chemistry|April 26, 2018
Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic ApproachMiguel Muñoz, Rafael Coveñas
Cancers|July 9, 2015
Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic ApproachMiguel Muñoz, Rafael Coveñas
Pageof 32

Showing results (1-10 of 320) with videos related to

Sort By:
Pageof 32
World Journal of Gastroenterology|April 3, 2009
Capsule endoscopyMiguel Muñoz-Navas
Archives of Sexual Behavior|November 7, 2018
Ethnic and Racial Specificity, or Not, in Bisexuality Research: A Practical CommentaryMiguel Muñoz-Laboy
Histology and Histopathology|February 19, 2014
Cancer progression and substance PRafael Coveñas, Miguel Muñoz
Expert Opinion on Therapeutic Patents|May 14, 2020
Neurokinin receptor antagonism: a patent review (2014-present)Miguel Muñoz, Rafael Coveñas
Journal of Clinical Medicine|June 5, 2020
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid LeukemiaMiguel Muñoz, Rafael Coveñas
Cancers|February 13, 2025
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine GliomaMiguel Muñoz, Marisa Rosso
Expert Opinion on Drug Safety|May 28, 2013
Safety of neurokinin-1 receptor antagonistsMiguel Muñoz, Rafael Coveñas
Archivos De Bronconeumologia|October 21, 2023
Long-term Use of Angiotensin-converting Enzyme Inhibitors Increases Substance P Levels, Which is Involved in the Risk of Lung CancerMiguel Muñoz, Antonio Pavon
Anti-Cancer Agents in Medicinal Chemistry|April 26, 2018
Glioma and Neurokinin-1 Receptor Antagonists: A New Therapeutic ApproachMiguel Muñoz, Rafael Coveñas
Cancers|July 9, 2015
Targeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic ApproachMiguel Muñoz, Rafael Coveñas
Pageof 32